Repurposing Vanoxerine as a new antimycobacterial drug and its impact on the mycobacterial membrane
A. D. H. Kingdon, A.-R. Meosa John, S. M. Batt, G. S. Besra
This study identifies vanoxerine as an antimycobacterial agent that disrupts mycobacterial membrane potential, inhibits efflux, and shows no resistance, supporting its development for tuberculosis treatment.
bioRxiv · Nov 29, 2022 · PreprintMicrobiology